NeolSyM, CITRUS, Absolicon Decarbonize Pharmaceutical Industry

NeolSyM, a Neolpharma Group company, and CITRUS have signed an agreement for the installation of a demo plant at its facilities in Ecatepec de Morelos, the State of Mexico. The full potential for solar heat installations at NeolSyM and other manufacturing plants of the group in Mexico is 25000m2. The initial installation is expected to commence in 2023 using the patented Absolicon T160 technology, with an operational temperature of up to 160°C heat and 8 bar steam.

A preliminary study from CITRUS shows that the total potential for solar heat installations within the group to which NeolSyM belongs in Mexico is approximately 25000m2. Initially, a solar collector field with a total size of 450m2 will be set up and following an evaluation period, the solar installation will provide the basis to define the scope and detailed design for a potential future expansion.

For more than 10 years, Neolpharma Group has voluntarily, ethically and transparently assumed responsibility for the social and environmental impacts of its operations, integrating decarbonization as part of its strategy and management model to consolidate as an organization committed to sustainability.

“At Grupo Neolpharma, energy management, climate change mitigation and emissions reduction are fundamental elements of the corporate strategy. Therefore, we have undertaken initiatives in each plant of the group that contribute to the achievement of our strategic objectives. We believe that with the CITRUS proposal, we can make Neolsym a reference in the medium term for the implementation of renewable energy alternatives in the processes of the group's plants,” said Felipe Neri, General Manager, NeolSyM.

Important Milestone Confirms that Decarbonization is Profitable and Achievable

“Mexico is one of the most important pharmaceutical markets worldwide and CITRUS is fully committed to transform it into a profitable and clean industry. The implementation of this demo plant together with NeolSyM, using the most efficient solar concentrator technology in the world, is a big step not only for NeolSyM but for the entire pharmaceutical industry as it will confirm that industrial decarbonization is profitable and realistic,” said Katia Bernal, CEO, CITRUS.

NeolSyM is a pharmacochemistry plant with more than 12 years of experience in the manufacture of Active Pharmaceutical Ingredients (APIs), with the mission to be a company dedicated to the development of active pharmaceutical ingredients for human health care with the necessary quality, service and price, which will allow them to be globally competitive and contribute to a better quality of life for the patients of those companies that it serves.

CITRUS is an engineering consultancy based in Mexico City, Mexico. CITRUS is an official production line partner to Absolicon and they work towards finding and integrating the right clean, competitive energy technologies and solutions for manufacturing. You can find more info about the CITRUS partnership with Absolicon in this press release.

Absolicon Solar Collector was established in 2005 as a research and development company in solar technology. Today, Absolicon is a publicly listed company with more than ten years of operational experience from all parts of the world. Absolicon specializes in providing tools for the transition from fossil fuels, providing a profitable, easy-to-install, and emission-free energy solution using solar thermal resources as well as complete robotic production lines for the solar collectors.